On 20 19/03/29 EST (China Beijing time 2065438+March 29th, 2009), the document S- 1 submitted by Jiufulai International Group (code: CNJG) came into effect after several rounds of approval by the SEC.
Kaifeng Jiufulai Biotechnology Co., Ltd. was established on 20 1 1, which is an enterprise specializing in aloe health industry such as organic planting, aloe raw material processing, aloe biological extraction, aloe anti-AIDS drugs and anti-tumor drugs.
The company is located in Zhengzhou, China, which is a traditional private enterprise in China.